These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10544939)

  • 1. Phenotypic expression of murine hemophilia.
    Muchitsch EM; Turecek PL; Zimmermann K; Pichler L; Auer W; Richter G; Gritsch H; Schwarz HP
    Thromb Haemost; 1999 Oct; 82(4):1371-3. PubMed ID: 10544939
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
    Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
    Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
    Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
    Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for hemophilia.
    Lynch CM
    Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice.
    Khallou-Laschet J; Caligiuri G; Tupin E; Gaston AT; Poirier B; Groyer E; Urbain D; Maisnier-Patin S; Sarkar R; Kaveri SV; Lacroix-Desmazes S; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):e123-6. PubMed ID: 15920033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
    Xu L; Mei M; Ma X; Ponder KP
    J Thromb Haemost; 2007 Sep; 5(9):1805-12. PubMed ID: 17596134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative measure of the efficacy of factor VIII in hemophilia A mice.
    Parker ET; Lollar P
    Thromb Haemost; 2003 Mar; 89(3):480-5. PubMed ID: 12624631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
    Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
    Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular pathogenesis of haemophilia A].
    Habart D
    Cas Lek Cesk; 2005; 144(11):727-32. PubMed ID: 16335697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB
    Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the factor VIII gene in thai hemophilia A patients.
    Akkarapatumwong V; Oranwiroon S; Pung-amritt P; Treesucon A; Thanootarakul P; Veerakul G; Mahasandana C; Panyim S; Yenchitsomanus P
    Hum Mutat; 2000 Jan; 15(1):117-8. PubMed ID: 10612839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of factor VIII in hemophilia.
    Yang G; Yao L; Lu Z
    N Engl J Med; 2009 Jul; 361(3):309; author reply 310. PubMed ID: 19610161
    [No Abstract]   [Full Text] [Related]  

  • 16. 11 hemophilia A patients without mutations in the factor VIII encoding gene.
    Klopp N; Oldenburg J; Uen C; Schneppenheim R; Graw J
    Thromb Haemost; 2002 Aug; 88(2):357-60. PubMed ID: 12195713
    [No Abstract]   [Full Text] [Related]  

  • 17. FVIII gene delivery by muscle electroporation corrects murine hemophilia A.
    Long YC; Jaichandran S; Ho LP; Tien SL; Tan SY; Kon OL
    J Gene Med; 2005 Apr; 7(4):494-505. PubMed ID: 15521095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major disorganization of factor VIII gene as a cause of severe hemophilia A in Indian patients.
    Shetty S; Ghosh K; Mohanty D
    Am J Hematol; 2004 May; 76(1):96. PubMed ID: 15114612
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced clinical severity in a mutationally well-characterized cohort of severe hemophilia with associated thrombophilia.
    Shetty S; Ghosh K
    Am J Clin Pathol; 2008 Jul; 130(1):84-7; quiz 146. PubMed ID: 18550475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of factor VIII intron 1 inversion in a cohort of severe hemophilia A Italian patients.
    Acquila M; Pasino M; Lanza T; Bottini F; Boeri E; Bicocchi MP
    Haematologica; 2003 May; 88(5):ELT17. PubMed ID: 12745291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.